Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kestra Medical Technologies (KMTS) Receivables (2024 - 2025)

Historic Receivables for Kestra Medical Technologies (KMTS) over the last 2 years, with Q4 2025 value amounting to $10.4 million.

  • Kestra Medical Technologies' Receivables changed N/A to $10.4 million in Q4 2025 from the same period last year, while for Oct 2025 it was $10.4 million, marking a year-over-year change of. This contributed to the annual value of $8.1 million for FY2025, which is 30445.45% up from last year.
  • As of Q4 2025, Kestra Medical Technologies' Receivables stood at $10.4 million.
  • Kestra Medical Technologies' 5-year Receivables high stood at $10.4 million for Q4 2025, and its period low was $2.0 million during Q2 2024.